U.S. Markets closed

NuVasive, Inc. (NUVA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
69.53+0.94 (+1.37%)
At close: 4:00PM EDT

69.53 0.00 (0.00%)
After hours: 4:59PM EDT

Sign in to post a message.
  • A
    Anonymous
    Covid delayed lots of procedures that will come back as revenue for this stock in coming quarters; stay long...
  • M
    MarketMania
    $MESO conversation
    To All New MESO shareholders and stem cell / MESO naysayers – a lot of us long-time shareholders (Minnesota, Left-e, Seanpierre1, Josephine, Frank/ Tarentella 123, Francesca, George, etc..) have been involved with Osiris for a very long time – some as early as the IPO, and others that have bought over the years. I first bought Osiris in 2011 after a lot of research and continued to buy over a period of years. When Osiris partnered with Mesoblast in October 2013, it was a huge disappointment in my mind – but in hindsight, is was a great decision by Peter Friedli. Peter knew that taking Prochymal – Remestemcel-L to market would have required a lot of capital/dilution. This enabled Osiris to focus on Grafix, GrafixPL, Stravix, etc. Peter was excellent at choosing the right partner for Osiris’ technology/science. NuVasive, Inc. $NUVA for Osteocel, Stryker Corporation $SYK for BIO4, Arthrex for BIO4, etc. until Smith & Nephew $SNN bought our Osiris in March of 2019. Peter was a co-founder of the Osiris along with Kevin Kimberlin. I would suggest EVERYONE search Kevin’s website – first and last name together dot com – to understand his background. I know some long term shareholders who had the opportunity to meet Kevin in the past at Osiris’ shareholders meetings. He is a very intelligent individual and his background is VERY IMPRESSIVE. The SCIENCE is ready for PRIME TIME. Anyone looking at the small sample size of the Covid-19 trial – need to look at the past trials and the success to draw any conclusions. Many of us have had the opportunity to tour Osiris’ headquarters in Maryland – their walls were lined with children that were saved by their SCIENCE. That was their motivation! Peter knew when to partner with the right company. We’ll see when/if MESO will partner with big pharma – hopefully it’s north of $75/share. Until then, do your own research and understand the science/history. We’re at a critical stage of stem cell therapies and MESO is the BEST horse in the race. Disclaimer: long a lot of $ATHX too! …. And the $MDXG Cheerleaders deserve a shout out to – you shouldn’t have drank Pete’s Kool-Aid and listened to Beef, Peter, Wendy, Frozen, BrianX, Homebuilder, etc. – they’re all clueless and people that follow them - continue to miss a great opportunity!
  • r
    roba
    Up huge AH...news?
  • W
    Will
    100% guaranteed today stock will go down. Because I'm buying it and I have really really bad luck.
  • Y
    Yahoo Finance Insights
    NUVA reached a 52 Week high at 69.80
  • R
    Rob
    Looking for some good earnings - fingers crossed !
    Bullish
  • W
    Will
    It's time to be real the stock is going down every day I think it's going to go down to a penny and is the reason for that it's a pump-and-dump stock.
  • Y
    Yahoo Finance Insights
    NuVasive is down 5.90% to 49.75
  • W
    Will
    It's trying to go up today but trying is not good enough
  • W
    Will
    I'm shocked but there is a real chance this stock can hit $1 a share this week small chance but a chance.
  • M
    Mel
    How do we even get the spin of shares? Do they appear in our brokerage account or are they mail to us
  • B
    Bill Johnston
    Feb 8 (Reuters) -

    * SMITH & NEPHEW IN TALKS TO BUY NUVASIVE FOR OVER $3 BILLION- FT Source text : https://on.ft.com/2UPdmzQ Further company coverage:
    FTSE 100 medical devices maker considers acquisition of spinal surgery specialist
    FTSE 100 medical devices maker considers acquisition of spinal surgery specialist
    on.ft.com
  • M
    Mel
    I'll be happy just to see the stock breaking dollar which doesn't seem possible .
  • S
    Stkpicker
    6 % growth is not going to cut it. Organic growth is even less. earnings of $2.45 at a 15x PE is $37 stock price. That is where it is headed
  • Y
    Yahoo Finance Insights
    NUVA is up 5.01% to 60.96
  • Y
    Yahoo Finance Insights
    NUVA is up 6.56% to 55.87
  • F
    Fern
    I think nuva is forgotten stock..
  • N
    Nick
    short
  • Y
    Yahoo Finance Insights
    NUVA is down -6.85% to 49.50
  • Y
    Yahoo Finance Insights
    NUVA is down -5.15% to 57.87